Comparative Pharmacology
Head-to-head clinical analysis: DISPERMOX versus PENICILLIN G POTASSIUM IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DISPERMOX versus PENICILLIN G POTASSIUM IN PLASTIC CONTAINER.
DISPERMOX vs PENICILLIN G POTASSIUM IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity and disrupting peptidoglycan cross-linking.
Penicillin G is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidation and activating autolytic enzymes.
Adults: 1 g (as amoxicillin 875 mg + clavulanate 125 mg) orally every 12 hours for 7-10 days.
2-4 million units IV every 4 hours for moderate to severe infections; up to 24 million units/day for serious infections (meningitis, endocarditis).
None Documented
None Documented
Terminal elimination half-life 1.5 hours; prolonged in renal impairment.
0.5–1 hour (normal renal function). Prolonged in renal impairment (up to 7–10 hours in anuria).
Renal excretion 80% as unchanged drug, biliary/fecal 10%.
Renal: 60–90% unchanged via tubular secretion and glomerular filtration. Biliary/fecal: <10%.
Category C
Category A/B
Penicillin Antibiotic
Penicillin Antibiotic